Literature DB >> 9202256

Decreased expression of murine PPARgamma in adipose tissue during endotoxemia.

M R Hill1, M D Young, C M McCurdy, J M Gimble.   

Abstract

Infection-induced hyperlipidemia develops due to a combination of factors, one of which is decreased clearance of lipids from the bloodstream due to depressed synthesis of lipoprotein lipase (LPL). Recently, the peroxisome proliferator activated receptors (PPARs) have been shown to be important in the regulation of LPL, particularly PPARgamma. PPARgamma and its heterodimerization partner, RXR alpha have been shown to be transcriptional activators of LPL in co-transfection analysis. Therefore, we hypothesized that the decrease in LPL expression during endotoxemia may be a result of depressed PPARgamma expression. In these studies, we examined the effect of endotoxin or its proximal mediator, tumor necrosis factor (TNF), on the expression of PPARgamma in white (WAT) and brown adipose tissue (BAT) in CD-1 mice. We report that treatment with endotoxin, but not TNF, transiently decreased PPARgamma mRNA levels 4 hr after treatment. However, endotoxin or TNF treatment decreased PPARgamma protein levels after 18 hr, which was at a time when LPL mRNA levels were also depressed. These data suggest that decreased PPARgamma expression following endotoxin or TNF treatment may contribute to the hyperlipidemia due to decreased expression of LPL, which would impair triglyceride clearance.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9202256     DOI: 10.1210/endo.138.7.5379

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  12 in total

1.  Inflammation inhibits GPR81 expression in adipose tissue.

Authors:  Kenneth R Feingold; Arthur Moser; Judy K Shigenaga; Carl Grunfeld
Journal:  Inflamm Res       Date:  2011-07-13       Impact factor: 4.575

2.  Epigenetic changes during mechanically induced osteogenic lineage commitment.

Authors:  Julia C Chen; Mardonn Chua; Raymond B Bellon; Christopher R Jacobs
Journal:  J Biomech Eng       Date:  2015-01-26       Impact factor: 2.097

3.  Decreased hepatic peroxisome proliferator-activated receptor-γ contributes to increased sensitivity to endotoxin in obstructive jaundice.

Authors:  Xin Lv; Jian-Gang Song; Hong-Hai Li; Jun-Ping Ao; Ping Zhang; Ye-Sheng Li; Shao-Li Song; Xiang-Rui Wang
Journal:  World J Gastroenterol       Date:  2011-12-28       Impact factor: 5.742

4.  Anti-inflammatory effects of PPAR-gamma agonists directly correlate with PPAR-gamma expression during acute pancreatitis.

Authors:  Michael D Rollins; Sharon Sudarshan; Matthew A Firpo; Brooke H Etherington; Brandon J Hart; Heidi H Jackson; Jeffrey D Jackson; Lyska L Emerson; David T Yang; Sean J Mulvihill; Robert E Glasgow
Journal:  J Gastrointest Surg       Date:  2006 Sep-Oct       Impact factor: 3.452

5.  Effect of peroxisome proliferator-activated receptor alpha activators on tumor necrosis factor expression in mice during endotoxemia.

Authors:  M R Hill; S Clarke; K Rodgers; B Thornhill; J M Peters; F J Gonzalez; J M Gimble
Journal:  Infect Immun       Date:  1999-07       Impact factor: 3.441

6.  Phosphorylation of extracellular signal-regulated kinase (ERK)-1/2 Is associated with the downregulation of peroxisome proliferator-activated receptor (PPAR)-γ during polymicrobial sepsis.

Authors:  Jennifer M Kaplan; Paul W Hake; Alvin Denenberg; Marchele Nowell; Giovanna Piraino; Basilia Zingarelli
Journal:  Mol Med       Date:  2010-08-19       Impact factor: 6.354

7.  Pioglitazone: a promising therapeutic tool in sodium taurocholate-induced severe acute pancreatitis.

Authors:  Ping Xu; Kai Xu; Jing Wang; Jin-Ping Jiang; Ling-Quan Chen
Journal:  Dig Dis Sci       Date:  2010-09-08       Impact factor: 3.199

8.  Novel Therapeutic Agents in Pediatric Sepsis: Peroxisome Proliferator Receptor γ (PPAR γ) Agonists.

Authors:  Jennifer M Kaplan; Basilia Zingarelli
Journal:  Open Inflamm J       Date:  2011-10-07

9.  Lung injury after hemorrhage is age dependent: role of peroxisome proliferator-activated receptor gamma.

Authors:  Basilia Zingarelli; Paul W Hake; Michael O'Connor; Timothy J Burroughs; Hector R Wong; Joseph S Solomkin; Alex B Lentsch
Journal:  Crit Care Med       Date:  2009-06       Impact factor: 7.598

10.  Nuclear control of the inflammatory response in mammals by peroxisome proliferator-activated receptors.

Authors:  Stéphane Mandard; David Patsouris
Journal:  PPAR Res       Date:  2013-03-07       Impact factor: 4.964

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.